Israel -
ebraică -
Ministry of Health
קרם רב שימושי - pnina rosenblum
א.ל. ארמן יצור תמרוקים בעמ - לחות לפנים
Israel -
ebraică -
Ministry of Health
קאנאג' קולור קולקשיון צלליות שפתיים (lipgloss)
כמיפל בעמ - איפור
Israel -
ebraică -
Ministry of Health
ונופר
cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.
Israel -
ebraică -
Ministry of Health
ונופר
cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.
Israel -
ebraică -
Ministry of Health
קוג'נייט fs 500 iu
bayer israel ltd - antihemophilic factor (recombinant) sucrose - אבקה להכנת תמיסה לזריקה - antihemophilic factor (recombinant) sucrose 500 iu/vial - blood coagulation factors - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor viii.routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with severe hemophilia a with no pre-existing joint damage. kogenate fs is not indicated for the treatment of von willebrand’s disease.
Israel -
ebraică -
Ministry of Health
קוג'נייט fs 1000 iu
bayer israel ltd - antihemophilic factor (recombinant) sucrose - אבקה להכנת תמיסה לזריקה - antihemophilic factor (recombinant) sucrose 1000 iu/vial - blood coagulation factors - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor viii.routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children under with severe hemophilia a with no pre-existing joint damage.kogenate fs is not indicated for the treatment of von willebrand’s disease.
Israel -
ebraică -
Ministry of Health
שמפו לשיער - english rose
א.ל. ארמן יצור תמרוקים בעמ - חפיפת שיער
Israel -
ebraică -
Ministry of Health
קונדישנר לשיער - english rose
א.ל. ארמן יצור תמרוקים בעמ - ריכוך השיער